Diabetic Retinopathy – Epidemiology – Epidemiology Dashboard

Clarivate Epidemiology’s coverage of diabetic retinopathy (DR) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of DR for each country as well as annualized case counts projected to the national population.

All patient populations are forecast over a period of 10 years for the major mature pharmaceutical markets and other countries covered in this report. In addition to forecasting incident and prevalent patient populations, we estimate the number of drug-treatment opportunities in specific lines of therapy in the major mature pharmaceutical markets.

Clarivate Epidemiology’s DR forecast will answer the following questions:

  • Of all people diagnosed with DR, how many in each of the major mature pharmaceutical markets are drug-treated?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of DR over the forecast period?

All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

Clarivate Epidemiology forecasts following DR patient populations:

  • Total prevalent cases.
  • Total prevalent cases by DR severity.
  • Total prevalent cases by diagnosis scheme.
  • Diagnosed prevalent cases by drug-treatment scheme.

Note: Coverage may vary by country.

launch Related Market Assessment Reports